A handful of drug companies rang in 2018 with price hikes that easily surpass inflation but stay conspicuously below double digits. Investment banks Jefferies and Cowen highlighted some of the big ones (listed below the fold).
Inside the White House with D.C.'s most wired reporter. Sign up for Mike Allen's Axios AM.
More stories loading.